A Study to Compare to PK Characteristics and Safety Profiles Between PA-111 and PA-111A

NCT06932705 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Mixed Dyslipidemia

Interventions

DRUG: PA-111
DRUG: PA-111A

Sponsor

Addpharma Inc.